In patients with class II disease, Tracleer caused the resistance of the blood vessels to decrease by 23% compared with placebo after six months of treatment, but the distance the patients could walk over six minutes was similar in the two groups.
Dog var den afstand, patienterne kunne gå på 6 minutter, ens i de to grupper.